Stockscreener 앱 받기
0.319
4.35%
-0.0145
시장 영업 전:
.35
0.031
+9.72%
Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
6.45%
0.029
|
0.031 | 0.016 | 0.373 | - |
Operating Expenses
|
18.68%
4.384
|
5.391 | 6.861 | 6.302 | 7.319 |
| Benefits Costs and Expenses |
24.37%
4.329
|
5.724 | 6.716 | 6.407 | 7.124 |
| Costs And Expenses |
24.37%
4.329
|
5.724 | 6.716 | 6.407 | 7.124 |
| Operating Income/Loss |
18.75%
-4.355
|
-5.36 | -6.845 | -5.929 | -7.319 |
| Nonoperating Income/Loss |
116.52%
0.055
|
-0.333 | 0.145 | -0.105 | 0.195 |
| Income/Loss From Continuing Operations Before Tax |
24.47%
-4.30
|
-5.693 | -6.70 | -6.034 | -7.124 |
| Income Tax Expense/Benefit |
220.85%
-1.354
|
-0.422 | -0.668 | -0.586 | -1.32 |
| Income/Loss From Continuing Operations After Tax |
44.11%
-2.946
|
-5.271 | -6.032 | -5.448 | -5.804 |
|
Net Income/Loss
|
44.58%
-2.946
|
-5.316 | -6.032 | -5.448 | -5.804 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Diluted Earnings Per Share |
-2.27
|
- | - | -0.44 | -0.47 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.53%
0.33%
자본화:
|
볼륨(24시간):